Booth Bruce
SEC insider (Form 3/4/5 filer). CIK 0001451612. Director at Kymera Therapeutics, Inc. (KYMR) and 2 other issuers. 227 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in WATERTOWN, MA.
Companies Booth Bruce has filed insider reports for
- Kymera Therapeutics, Inc. (KYMR): Director
- Sionna Therapeutics, Inc. (SION): Director
- Vigil Neuroscience, Inc. (VIGL): Director
Booth Bruce
CIK: 0001451612
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (227 total)
- Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect7.7K shares at avg. $110.67$855K - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect2.1K shares at avg. $106.63$227K - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect19.4K shares at avg. $107.76$2.1M - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect8K shares at avg. $109.75$874K - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect934 shares at avg. $111.20$104K - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect770 shares at avg. $105.78$81K - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect5.5K shares at avg. $105.78$587K - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect14.8K shares at avg. $106.63$1.6M - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect10.8K shares at avg. $108.28$1.2M - Jun 29, 2026KYMR
Kymera Therapeutics, Inc.
SaleIndirect2.7K shares at avg. $107.76$291K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 |  KYMR Kymera Therapeutics, Inc. | Sale | 7,723 | $110.67 | $854,704 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 2,133 | $106.63 | $227,442 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 19,419 | $107.76 | $2,092,591 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 7,968 | $109.75 | $874,488 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 934 | $111.20 | $103,861 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 770 | $105.78 | $81,451 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 5,549 | $105.78 | $586,973 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 14,798 | $106.63 | $1,577,911 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 10,848 | $108.28 | $1,174,621 | Indirect |
| Jun 29, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 2,698 | $107.76 | $290,736 | Indirect |
1-10 of 227 transactions